- Home
- EVCM vs ARQT Comparison
EVCM vs ARQT Comparison
Compare EVCM & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVCM
- ARQT
- Stock Information
- Founded
- EVCM 2006
- ARQT 2016
- Country
- EVCM United States
- ARQT United States
- Employees
- EVCM N/A
- ARQT N/A
- Industry
- EVCM EDP Services
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- EVCM Technology
- ARQT Health Care
- Exchange
- EVCM Nasdaq
- ARQT Nasdaq
- Market Cap
- EVCM 1.7B
- ARQT 1.7B
- IPO Year
- EVCM 2021
- ARQT 2020
- Fundamental
- Price
- EVCM $10.65
- ARQT $15.00
- Analyst Decision
- EVCM Buy
- ARQT Strong Buy
- Analyst Count
- EVCM 12
- ARQT 6
- Target Price
- EVCM $11.67
- ARQT $18.80
- AVG Volume (30 Days)
- EVCM 258.1K
- ARQT 1.9M
- Earning Date
- EVCM 08-05-2025
- ARQT 08-13-2025
- Dividend Yield
- EVCM N/A
- ARQT N/A
- EPS Growth
- EVCM N/A
- ARQT N/A
- EPS
- EVCM N/A
- ARQT N/A
- Revenue
- EVCM $703,186,000.00
- ARQT $212,819,000.00
- Revenue This Year
- EVCM N/A
- ARQT $61.01
- Revenue Next Year
- EVCM $6.31
- ARQT $37.95
- P/E Ratio
- EVCM N/A
- ARQT N/A
- Revenue Growth
- EVCM 7.84
- ARQT 100.03
- 52 Week Low
- EVCM $8.10
- ARQT $7.86
- 52 Week High
- EVCM $12.35
- ARQT $17.75
- Technical
- Relative Strength Index (RSI)
- EVCM 58.09
- ARQT 60.23
- Support Level
- EVCM $10.53
- ARQT $13.06
- Resistance Level
- EVCM $10.88
- ARQT $15.36
- Average True Range (ATR)
- EVCM 0.30
- ARQT 0.66
- MACD
- EVCM 0.06
- ARQT 0.12
- Stochastic Oscillator
- EVCM 79.67
- ARQT 82.57
About EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is primarily generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.